GlassScriptPhysician profile
Kelli Holland
NPI 1962108837
$3,047.19
in general payments reported to CMS, 2019-2025
28 companies · $553 in 2025
The $553 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,306 · 2024: $1,189 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,796 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,796.22 |
| Education | $250.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $766.78 | 2023-2025 | Breztri, Farxiga, Fasenra |
| Genzyme Corporation | $277.65 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $212.55 | 2023-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $202.25 | 2023-2024 | Yupelri |
| Shionogi INC | $178.59 | 2023-2025 | Fetroja |
| Bayer Healthcare Pharmaceuticals INC. | $165.27 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.56 | 2023-2024 | Glassia |
| Sanofi-Aventis U.S. LLC | $150.98 | 2023-2024 | |
| Abiomed | $80.94 | 2024 | Impella |
| Philips North America LLC | $68.33 | 2023-2024 | (Ak6) Vest Therapy |
| Otsuka America Pharmaceutical, INC. | $67.66 | 2023-2024 | Rexulti |
| Inspire Medical Systems, INC. | $67.09 | 2023-2025 | Inspire |
| Pulmonx Corporation | $66.35 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Baxter Healthcare | $64.08 | 2023 | Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Itamar Medical INC | $59.85 | 2023-2024 | Watchpatone |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $55.78 | 2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.42 | 2023-2024 | Ofev |
| Novo Nordisk INC | $52.76 | 2023-2024 | |
| Chiesi USA, INC. | $47.17 | 2023-2025 | Kengreal, Cleviprex |
| Regeneron Healthcare Solutions, INC. | $46.04 | 2025 | Dupixent |
| Grifols USA, LLC | $34.90 | 2024-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $33.47 | 2024 | Tyvaso |
| Abbvie INC. | $31.83 | 2025 | |
| Exact Sciences Corporation | $30.83 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $24.94 | 2023 | Mounjaro |
| Mallinckrodt Hospital Products INC. | $22.82 | 2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $16.50 | 2024 | Ultomiris |
| Glaxosmithkline, LLC. | $14.80 | 2024 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.